Congenital: Cardiomyopathy
Effects of pulmonary artery banding in doxorubicin-induced left ventricular cardiomyopathy
Central pulmonary banding has been proposed as a novel alternative for the treatment of left ventricular dilated cardiomyopathy in children. We sought to investigate the effects of central pulmonary banding in an experimental model of doxorubicin-induced left ventricular dilated cardiomyopathy.From genetics to prognosis
Cardiomyopathies in childhood are challenging cardiac disorders that carry high mortalities. Cardiac transplantation is the treatment of choice in case of intractable cardiac failure; however, the chronic shortage of donor organs hinders its unlimited application. Medical and surgical management strategies evolve steadily to improve the outcomes of our patients. Better risk stratification and novel alternatives for medical and surgical treatment options are therefore required.1,2
